FDA.reportPublic FDA data

24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo]

RxCUI
2630147
RxNorm name
24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo]
Display name
24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo]
Full name
24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7ea3c60a-45c7-44cc-afc2-d87fa53993c0Austedo XR 12 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo] [SBD] · Austedo 12 MG 24 HR Extended Release Oral Tablet [SY]335These highlights do not include all the information needed to use AUSTEDO XR or AUSTEDO safely and effectively. See full prescribing information for AUSTEDO XR and AUSTEDO . AUSTEDO XR ® (deutetrabenazine) extended-release tablets, for oral use AUSTEDO ® (deutetrabenazine) tablets, for oral use Initial U.S. Approval: 201720250228